drugset / Trial / NCT00885989
Safety and Tolerability of the First IV Dosing of SLV338 in Healthy Volunteers
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will investigate the safety and tolerability of the first IV dosing of SLV338 in healthy volunteers.
Timeline
- Start
- 2009-05
- Primary completion
- 2009-12
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SLV338 | Unknown | 5 mg | Intravenous |
| Subject | SLV338 | Unknown | 1000 mg | Intravenous |
Indications
No indication recorded.